Growth in the use of antibiotics in the community in England and Scotland in 1980-93

British Medical Journal

Volumn 312, Issue 7031, 1996, Pages 613-

  Davey, P G ^a   Bax, R P ^b   Newey, J ^c   Reeves, D ^d   Rutherford, D ^e   Slack, R ^f   Warren, R E ^g   Watt, B ^h   Wilson, J ⁱ  

^a NINEWELLS HOSPITAL   (United Kingdom)

^b GLAXOSMITHKLINE   (United Kingdom)

^c Weaver Vale   (United Kingdom)

^d SOUTHMEAD HOSPITAL   (United Kingdom)

^e Pipelands Health Centre   (United Kingdom)

^f PUBLIC HEALTH ENGLAND   (United Kingdom)

^g Public Health Laboratory   (United Kingdom)

^h CITY HOSPITAL   (United Kingdom)

ⁱ Family Health Services Authority   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOPENICILLIN; AMPICILLIN; ANTIBIOTIC AGENT; ANTIINFECTIVE AGENT; CEPHALOSPORIN DERIVATIVE; MACROLIDE; PENICILLIN V; QUINOLONE; SULFONAMIDE; TETRACYCLINE;

ARTICLE; DRUG USE; PRESCRIPTION; PRIORITY JOURNAL; UNITED KINGDOM;

EID: 0029926750     PISSN: 09598146     EISSN: None     Source Type: Journal    
DOI: 10.1136/bmj.312.7031.613     Document Type: Article

References (4)

1. Taboulet F. Presentation d'une methodologie permettant de mesurer en quantite et de comparer les consommations pharmaceutiques. J d'Econ Medicale 1990;8:37-63.
2. Davey PG, Parker SE, Malek MM. Pharmacoeconomics of antibacterial treatment. PharmacoEconomics 1992;1:409-437.
3. McGavock H, Webb CH, Johnston GD, Milligan E. Market penetration of new drugs in one United Kingdom region: implications for general practitioners and administrators. BMJ 1993;307:1118-1120.
4. Border P. Diseases fighting back - the growing resistance of TB and other bacterial diseases to treatment. London: Parliamentary Office of Science and Technology, 1994:1-38.